Coding Manual:
Hematopoietic Coding Manual (PDF)
Abstractor Notes
(This code is effective for cases diagnosed 2010 and later. For cases diagnosed prior to 2010 see code 9801/3.)
This is a rare leukemia that is more common in children than in adults. Patients with B/myeloid leukemia with MLL translocations are often treated differently from patients diagnosed with ALL with MLL translocations, but there is no evidence that the difference in treatment is necessary or helpful.
This is a rare leukemia that is more common in children than in adults. Patients with B/myeloid leukemia with MLL translocations are often treated differently from patients diagnosed with ALL with MLL translocations, but there is no evidence that the difference in treatment is necessary or helpful.
Diagnostic Confirmation
This histology can only be determined by positive genetics and/or immunophenotyping, diagnostic confirmation will always be 3.
Grade
Not Applicable
Module Rule
None
Alternate Names
Definition
Mixed-phenotype acute leukemia (MPAL) with t(v;11q23.3) fulfills the criteria for MPAL and has blasts with a translocation involving KMT2A (previously called MLL).
Definitive Diagnostic Methods
Bone marrow biopsy
FISH
Genetic testing
Immunophenotyping
Karyotyping
Polymerase chain reaction (PCR)
Genetics Data
AFF1 (AF4) on chromosome 4 band q21
KMT2A rearrangement
Immunophenotyping
CD10- (no expression/negative)
CD15+ (expression/positive)
CD19+ (expression/positive)
CD22+ (expression/positive)
CD79a+ (expression/positive)
Treatments
Chemotherapy
Hematologic Transplant and/or Endocrine Procedures
Transformations to
There are no known transformations
Transformations from
There are no known transformations
Same Primaries
Corresponding ICD-9 Codes
208.0 Acute leukemia of unspecified cell type
Corresponding ICD-10 Codes
C95.0 Acute leukemia of unspecified cell type
Corresponding ICD-10-CM Codes (U.S. only)
C95.0 Acute leukemia of unspecified cell type (effective October 01, 2015)
Signs and Symptoms
Diagnostic Exams
Progression and Transformation
None
Epidemiology and Mortality
Sources
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (Eds):
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th edition)
IARC: Lyon 2017
Section: Acute leukemias of ambiguous terminology
Pages: 183-184
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th edition)
IARC: Lyon 2017
Section: Acute leukemias of ambiguous terminology
Pages: 183-184
International Classification of Diseases for Oncology, Third Edition, Second Revision. Geneva: World Health Organization, 2020.
Section: ICD-O-3.2 (2020) Morphological Codes
Pages: http://www.iacr.com.fr/index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577
Section: ICD-O-3.2 (2020) Morphological Codes
Pages: http://www.iacr.com.fr/index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577